Published in Women's Health Weekly, May 12th, 2005
These findings are important because several commonly prescribed antiepileptic drugs (AEDs) may reduce the effectiveness of oral contraceptives, a potentially serious drug interaction for some women with epilepsy.
Findings from this single-center, open-label cross-over study were reported at the American Academy of Neurology's 57th Annual Meeting. Zonegran is an AED approved by the U.S. Food and Drug Administration (FDA) as adjunctive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.